HomeADIL • NASDAQ
Adial Pharmaceuticals Inc
add
$0.35
1.99%
After Hours:(2.03%)+0.0071
$0.36
Closed: Oct 31, 8:00:00 PM UTC-4 · USD · NASDAQ · Disclaimer
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 1.88M | -17.69% |
Net income | -1.96M | 20.33% |
Net profit margin | — | — |
Earnings per share | -0.18 | 69.49% |
EBITDA | -1.88M | 17.69% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 5.91M | 79.89% |
Total assets | 6.80M | 37.44% |
Total liabilities | 1.21M | 80.24% |
Total equity | 5.59M | — |
Shares outstanding | 21.83M | — |
Price to book | 1.37 | — |
Return on assets | -91.81% | — |
Return on capital | -121.98% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -1.96M | 20.33% |
Cash from operations | -1.75M | 18.57% |
Cash from investing | 0.00 | — |
Cash from financing | 5.30M | 1,188.88% |
Net change in cash | 3.55M | 304.32% |
Free cash flow | -1.07M | 20.55% |
Previous close
$0.36
Day range
$0.34 - $0.36
Year range
$0.22 - $1.30
Market cap
7.56M USD
Avg Volume
705.96K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2010
Headquarters
Website
Employees
5
